PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.77%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-6.75%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-31.49%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-35.54%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-32.23%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-32.22%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-32.22%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
58.88%
10Y CAGR of 58.88% while 3391.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
-14.93%
Negative 5Y CAGR while 3391.T stands at 76.81%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
36.94%
3Y revenue/share CAGR similar to 3391.T's 39.21%. Walter Schloss would assume both companies experience comparable short-term cycles.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
127.10%
10Y net income/share CAGR of 127.10% while 3391.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
-26.01%
Negative 5Y net income/share CAGR while 3391.T is 82.63%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
18.92%
Below 50% of 3391.T's 50.81%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
175.31%
Equity/share CAGR of 175.31% while 3391.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
21.78%
Below 50% of 3391.T's 83.32%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
68.66%
3Y equity/share CAGR 1.25-1.5x 3391.T's 45.79%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
12.50%
Below 50% of 3391.T's 180.00%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
-18.18%
Negative near-term dividend growth while 3391.T invests at 98.58%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
8.70%
AR growth is negative/stable vs. 3391.T's 28.16%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
9.23%
Inventory growth well above 3391.T's 15.03%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.72%
Asset growth well under 50% of 3391.T's 12.63%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.25%
Under 50% of 3391.T's 7.68%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-7.42%
We’re deleveraging while 3391.T stands at 39.45%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
1.66%
SG&A growth well above 3391.T's 1.85%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.